Battery Global Advisors’s Amgen AMGN Stock Holding History

Battery Global Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.5K	Hold	243	–	–	0.05%	64
2025 Q4	$79.5K	Hold	243	–	–	0.04%	64
2025 Q3	$68.6K	Hold	243	–	–	0.03%	66
2025 Q2	$67.8K	Hold	243	–	–	0.03%	62
2025 Q1	$75.7K	Buy	243 +4	+2%	+$1.18K	0.04%	56
2024 Q4	$62.3K	Hold	239	–	–	0.03%	63
2024 Q3	$77K	Buy	+239	New	+$78.2K	0.04%	57

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Battery Global Advisors's AMGN Position: Q1 2026 in Review

Battery Global Advisors held its Amgen (AMGN) position steady in Q1 2026 at 243 shares worth $85.5K. The position accounts for 0.05% of the portfolio, ranked #64.

Battery Global Advisors first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Battery Global Advisors held 243 shares of Amgen worth $85.5K as of Q1 2026.
Battery Global Advisors left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.05% of Battery Global Advisors's portfolio in Q1 2026, its #64 holding.
Battery Global Advisors first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Battery Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.